✦ LIBER ✦
Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH
✍ Scribed by Yuki Kimura; Hideyuki Hyogo; Sho-ichi Yamagishi; Masayoshi Takeuchi; Tomokazu Ishitobi; Yoshitaka Nabeshima; Koji Arihiro; Kazuaki Chayama
- Publisher
- Springer Japan
- Year
- 2010
- Tongue
- English
- Weight
- 202 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.